Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic Saline [NA]
This completed clinical trial evaluated managing allergic rhinitis with nasal steroids in combination with the NeilMed Sinus Rinse System us…
-
FDA approval · 2018-07-20FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Chewable Grape and Bubblegum (loratadine) from Bayer HealthCare LLC.
-
FDA approval · 2018-07-20FDA Approved: CLARITIN LIQUI-GELS — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Liqui-Gels (loratadine) from Bayer HealthCare LLC.
-
FDA approval · 2018-07-20FDA Approved: CETIRIZINE HYDROCHLORIDE (ALLERGY) — Original Application (RITE AID CORPORATION)
FDA approves Rite Aid's original ANDA for cetirizine hydrochloride (allergy). It is a generic antihistamine used to treat allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of acupuncture combined with moxibustion for perennial allergic rhinitis has been comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-07-05FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin (loratadine) filed by Bayer HealthCare LLC.
-
FDA approval · 2018-07-03FDA Approved: BUDESONIDE — Original Application (Actavis Pharma, Inc.)
FDA approved the original application for Budesonide from Actavis Pharma, Inc. (ANDA205457).
-
FDA approval · 2018-07-02FDA Approved: MONTELUKAST SODIUM — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original ANDA for montelukast sodium from Unichem Pharmaceuticals (USA), Inc., establishing a generic version of this asthm…
-
FDA approval · 2018-06-29FDA Approved: LORATADINE — Original Application (Better Living Brands LLC)
FDA approves the original ANDA for loratadine oral by Better Living Brands LLC, authorizing its generic product.
-
FDA label_change · 2018-06-27FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for levocetirizine dihydrochloride (Glenmark Pharmaceuticals Inc., USA) under the ANDA process, lead…
-
FDA approval · 2018-06-20FDA Approved: CLARITIN LIQUI-GELS — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application to add CLARITIN LIQUI-GELS (loratadine) as a new dosage form for Claritin. This expands the prod…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Phase II HDM-SPIRE Safety and Efficacy Study [Phase 2]
Phase II safety and efficacy study of HDM-SPIRE for rhinoconjunctivitis has completed, with results posted in 2018.
-
FDA approval · 2018-06-08FDA Approved: PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE by Amneal Pharmaceuticals LLC.
-
FDA label_change · 2018-06-04FDA Approved: CLARITIN LIQUI-GELS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Liqui-Gels (loratadine) from Bayer HealthCare LLC.
-
FDA approval · 2018-06-01FDA Approved: TOPCARE CHILDRENS ALLERGY — Supplemental Application (Topco Associates LLC)
The FDA approved a supplemental application for TOPCARE CHILDRENS ALLERGY (loratadine) from Topco Associates LLC, authorizing a labeling upd…
-
FDA approval · 2018-05-30FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin (loratadine) filed by Bayer HealthCare LLC.
-
FDA approval · 2018-05-25FDA Approved: NASAL ALLERGY — Supplemental Application (Kroger Company)
The FDA approved a supplemental application for a generic nasal spray product called NASAL ALLERGY containing triamcinolone acetonide, manuf…
-
FDA approval · 2018-05-21FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for a generic version of levocetirizine dihydrochloride from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2018-05-18FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for Montelukast Sodium.
-
FDA approval · 2018-05-18FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for montelukast submitted by BluePoint Laboratories under ANDA 203366. The decision denotes appr…
-
FDA approval · 2018-05-14FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) from Bayer HealthCare LLC, approving the supplemental action relat…
-
FDA approval · 2018-05-14FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for montelukast sodium from Unichem Pharmaceuticals (USA), Inc., indicating approval of an additiona…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine [Phase 4]
Phase 4 clinical trial comparing bilastine and loratadine in allergic rhinitis evaluated quality of life outcomes.
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients [Phase 2]
Phase 2 clinical trial evaluating benjakul extract in combination with loratadine for allergic rhinitis has completed.
-
FDA approval · 2018-04-19FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)
FDA has approved a supplemental application for CLARINEX-D 12 HOUR (desloratadine and pseudoephedrine sulfate) submitted by Organon LLC.